Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1972 Dec;46(4):585–593. doi: 10.1111/j.1476-5381.1972.tb06885.x

The effects of dipyridamole on the myocardial vasodilator actions of noradrenaline, isoprenaline and adenosine

J R Parratt, R M Wadsworth
PMCID: PMC1666377  PMID: 4655263

Abstract

1. In anaesthetized cats, intravenous adenosine infusions decreased resistance to blood flow in the myocardial vascular bed. This effect of adenosine was augmented during the 60 min following the intravenous injection of dipyridamole (1 mg/kg).

2. In different experiments, intravenous infusions of noradrenaline caused either a slight increase or a slight decrease in myocardial vascular resistance. The dilator component of the action of noradrenaline was not augmented by dipyridamole.

3. Isoprenaline infusions decreased the resistance of the myocardial bed. This effect was unaltered after dipyridamole.

4. These results do not support the hypothesis that part of the effect of catecholamines on myocardial vascular resistance involves the release of adenosine from hypoxic myocardial cells.

Full text

PDF
585

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERNE R. M. REGULATION OF CORONARY BLOOD FLOW. Physiol Rev. 1964 Jan;44:1–29. doi: 10.1152/physrev.1964.44.1.1. [DOI] [PubMed] [Google Scholar]
  2. BRAUNWALD E., SARNOFF S. J., CASE R. B., STAINSBY W. N., WELCH G. H., Jr Hemodynamic determinants of coronary flow: effect of changes in aortic pressure and cardiac output on the relationship between myocardial oxygen consumption and coronary flow. Am J Physiol. 1958 Jan;192(1):157–163. doi: 10.1152/ajplegacy.1957.192.1.157. [DOI] [PubMed] [Google Scholar]
  3. BRETSCHNEIDER H. J., FRANK A., BERNARD U., KOCHSIEK K., SCHELER F. Die Wirkung eines Pyrimidopyrimidin-Derivates auf die Sauerstoffversorgung des Herzmuskels. Arzneimittelforschung. 1959 Jan;9(1):49–59. [PubMed] [Google Scholar]
  4. Berne R. M., Rubio R., Dobson J. G., Jr, Curnish R. R. Adenosine and adenine nucleotides as possible mediators of cardiac and skeletal muscle blood flow regulation. Circ Res. 1971 Jan;28(Suppl):115+–115+. [PubMed] [Google Scholar]
  5. Bowman W. C., Stafford A. Effects of dipyridamole on contractions of the cat's nictitating membrane. Eur J Pharmacol. 1968 May;3(2):131–138. doi: 10.1016/0014-2999(68)90064-2. [DOI] [PubMed] [Google Scholar]
  6. Broadley K. J. An analysis of the coronary vascular responses to catecholamines, using a modified Langendorff heart preparation. Br J Pharmacol. 1970 Dec;40(4):617–629. doi: 10.1111/j.1476-5381.1970.tb10642.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gaal P. G., Kattus A. A., Kolin A., Ross G. Effects of adrenaline and noradrenaline on coronary blood flow before and after beta-adrenergic blockade. Br J Pharmacol Chemother. 1966 Mar;26(3):713–722. doi: 10.1111/j.1476-5381.1966.tb01851.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grayson J., Coulson R. L., Winchester B. Internal calorimetry--assessment of myocardial blood flow and heat production. J Appl Physiol. 1971 Feb;30(2):251–257. doi: 10.1152/jappl.1971.30.2.251. [DOI] [PubMed] [Google Scholar]
  9. HASHIMOTO K., SHIGEI T., IMAI S., SAITO Y., YAGO N., UEI I., CLARK R. E. Oxygen consumption and coronary vascular tone in the isolated fibrillating dog heart. Am J Physiol. 1960 May;198:965–970. doi: 10.1152/ajplegacy.1960.198.5.965. [DOI] [PubMed] [Google Scholar]
  10. Hashimoto K., Sano N. Potentiation of the coronary vasodilator effect of norepinephrine by 2,6-bis (diethanolamino)-4,8-dipiperidino-pyrimido (5,4-d) pyrimidine (dipyridamole). Tohoku J Exp Med. 1968 Oct;96(2):207–208. doi: 10.1620/tjem.96.207. [DOI] [PubMed] [Google Scholar]
  11. Katori M., Berne R. M. Release of adenosine from anoxic hearts. Relationship to coronary flow. Circ Res. 1966 Aug;19(2):420–425. doi: 10.1161/01.res.19.2.420. [DOI] [PubMed] [Google Scholar]
  12. Kübler W., Spieckermann P. G., Bretschneider H. J. Influence of dipyridamol (Persantin) on myocardial adenosine metabolism. J Mol Cell Cardiol. 1970 Mar;1(1):23–38. doi: 10.1016/0022-2828(70)90026-x. [DOI] [PubMed] [Google Scholar]
  13. McInnes L., Parratt J. R. Studies on the mode of action of hexobendine, a prospective anti-anginal drug. Br J Pharmacol. 1969 Sep;37(1):272–282. doi: 10.1111/j.1476-5381.1969.tb09544.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. OLSSON R. A., GREGG D. E. METABOLIC RESPONSES DURING MYOCARDIAL REACTIVE HYPEREMIA IN THE UNANESTHETIZED DOG. Am J Physiol. 1965 Feb;208:231–236. doi: 10.1152/ajplegacy.1965.208.2.231. [DOI] [PubMed] [Google Scholar]
  15. PARRATT J. R. BLOCKAGE OF SYMPATHETIC BETA-RECEPTORS IN THE MYOCARDIAL CIRCULATION. Br J Pharmacol Chemother. 1965 Jun;24:601–611. doi: 10.1111/j.1476-5381.1965.tb01616.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Parratt J. R., Wadsworth R. M. The effect of "selective" beta-adrenoceptor blocking drugs on the myocardial circulation. Br J Pharmacol. 1970 Jun;39(2):296–308. doi: 10.1111/j.1476-5381.1970.tb12893.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Parratt J. R., Wadsworth R. M. The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats. Br J Pharmacol. 1970 May;38(3):554–571. doi: 10.1111/j.1476-5381.1970.tb10597.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Parratt J. R., Wadsworth R. M. The effects of dipyridamole on coronary post-occlusion hyperaemia and on myocardial vasodilatation induced by systemic hypoxia. Br J Pharmacol. 1972 Dec;46(4):594–601. doi: 10.1111/j.1476-5381.1972.tb06886.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pfleger K., Niederau D., Volkmer I. Ein Beitrag zum Wirkungsmechanismus von Dipyridamol: Hemmung der Adenosinaufnahme in Erythrocyten durch Dipyridamol. Naunyn Schmiedebergs Arch Pharmakol. 1969;265(2):118–130. [PubMed] [Google Scholar]
  20. Raberger G., Kraupp O. Enhancement of the coronary dilator effect of intravenous and intracoronary administered adenosine by hexobendine in dogs. Eur J Pharmacol. 1971;13(3):312–319. doi: 10.1016/0014-2999(71)90220-2. [DOI] [PubMed] [Google Scholar]
  21. Rubio R., Berne R. M., Katori M. Release of adenosine in reactive hyperemia of the dog heart. Am J Physiol. 1969 Jan;216(1):56–62. doi: 10.1152/ajplegacy.1969.216.1.56. [DOI] [PubMed] [Google Scholar]
  22. Stafford A. Potentiation of adenosine and the adenine nucleotides by dipyridamole. Br J Pharmacol Chemother. 1966 Nov;28(2):218–227. doi: 10.1111/j.1476-5381.1966.tb01888.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES